{ "cik": 1528287, "cik_padded": "0001528287", "entityName": "NeuroPace Inc", "fiscal_years": [ { "accn": "0001528287-26-000011", "filed": "2026-03-03", "fiscal_year": 2025, "form": "10-K", "fundamental_units": { "buybacks": "USD", "capex": "USD", "cash": "USD", "cost_of_revenue": "USD", "eps_diluted": "USD/shares", "free_cash_flow": "USD", "gross_profit": "USD", "net_income": "USD", "operating_cash_flow": "USD", "operating_income": "USD", "revenue": "USD", "stockholders_equity": "USD", "total_assets": "USD", "total_liabilities": "USD" }, "fundamentals": { "buybacks": 49546000.0, "capex": 332000.0, "cash": 21692000.0, "cost_of_revenue": 22766000.0, "eps_diluted": -0.66, "free_cash_flow": -11338000.0, "gross_profit": 77220000.0, "net_income": -21465000.0, "operating_cash_flow": -11006000.0, "operating_income": -16338000.0, "revenue": 99986000.0, "stockholders_equity": 19031000.0, "total_assets": 105565000.0, "total_liabilities": 86534000.0 }, "period_end": "2025-12-31", "ratio_units": { "gross_margin": "ratio", "leverage": "ratio", "net_margin": "ratio", "operating_margin": "ratio", "revenue_growth_yoy": "ratio", "roa_avg2y": "ratio", "roa_period_end": "ratio", "roe_avg2y": "ratio", "roe_period_end": "ratio" }, "ratios": { "gross_margin": 0.7723081231372392, "leverage": 4.547002259471388, "net_margin": -0.2146800552077291, "operating_margin": -0.16340287640269635, "revenue_growth_yoy": 0.2512952719445348, "roa_avg2y": -0.2144227119253591, "roa_period_end": -0.20333443849760807, "roe_avg2y": -1.58741310457033, "roe_period_end": -1.1278965897745783 } }, { "accn": "0001528287-26-000011", "filed": "2026-03-03", "fiscal_year": 2024, "form": "10-K", "fundamental_units": { "buybacks": "USD", "capex": "USD", "cash": "USD", "cost_of_revenue": "USD", "eps_diluted": "USD/shares", "free_cash_flow": "USD", "gross_profit": "USD", "net_income": "USD", "operating_cash_flow": "USD", "operating_income": "USD", "revenue": "USD", "stockholders_equity": "USD", "total_assets": "USD", "total_liabilities": "USD" }, "fundamentals": { "buybacks": 0.0, "capex": 306000.0, "cash": 13430000.0, "cost_of_revenue": 20821000.0, "eps_diluted": -0.93, "free_cash_flow": -18255000.0, "gross_profit": 59085000.0, "net_income": -27141000.0, "operating_cash_flow": -17949000.0, "operating_income": -21671000.0, "revenue": 79906000.0, "stockholders_equity": 8013000.0, "total_assets": 94647000.0, "total_liabilities": 86634000.0 }, "period_end": "2024-12-31", "ratio_units": { "gross_margin": "ratio", "leverage": "ratio", "net_margin": "ratio", "operating_margin": "ratio", "revenue_growth_yoy": "ratio", "roa_avg2y": "ratio", "roa_period_end": "ratio", "roe_avg2y": "ratio", "roe_period_end": "ratio" }, "ratios": { "gross_margin": 0.7394313318148825, "leverage": 10.811681018345189, "net_margin": -0.33966160238279985, "operating_margin": -0.27120616724651464, "revenue_growth_yoy": 0.22141208480457344, "roa_avg2y": -0.2683269236472926, "roa_period_end": -0.28676027766331735, "roe_avg2y": -1.8935361216730038, "roe_period_end": -3.3871209284912016 } }, { "accn": "0001528287-26-000011", "filed": "2026-03-03", "fiscal_year": 2023, "form": "10-K", "fundamental_units": { "capex": "USD", "cash": "USD", "cost_of_revenue": "USD", "eps_diluted": "USD/shares", "free_cash_flow": "USD", "gross_profit": "USD", "net_income": "USD", "operating_cash_flow": "USD", "operating_income": "USD", "revenue": "USD", "stockholders_equity": "USD", "total_assets": "USD", "total_liabilities": "USD" }, "fundamentals": { "capex": 173000.0, "cash": 18058000.0, "cost_of_revenue": 17299000.0, "eps_diluted": -1.27, "free_cash_flow": -19874000.0, "gross_profit": 48122000.0, "net_income": -32956000.0, "operating_cash_flow": -19701000.0, "operating_income": -27174000.0, "revenue": 65421000.0, "stockholders_equity": 20654000.0, "total_assets": 107651000.0, "total_liabilities": 86997000.0 }, "period_end": "2023-12-31", "ratio_units": { "gross_margin": "ratio", "leverage": "ratio", "net_margin": "ratio", "operating_margin": "ratio", "revenue_growth_yoy": "ratio", "roa_avg2y": "ratio", "roa_period_end": "ratio", "roe_avg2y": "ratio", "roe_period_end": "ratio" }, "ratios": { "gross_margin": 0.7355742040017731, "leverage": 4.212113876246732, "net_margin": -0.5037526176609957, "operating_margin": -0.4153712110790113, "revenue_growth_yoy": 0.43719244288224957, "roa_avg2y": -0.2972262431400136, "roa_period_end": -0.30613742556966494, "roe_avg2y": -1.1890819216683806, "roe_period_end": -1.595623123850102 } }, { "accn": "0001528287-25-000007", "filed": "2025-03-04", "fiscal_year": 2022, "form": "10-K", "fundamental_units": { "capex": "USD", "cash": "USD", "cost_of_revenue": "USD", "eps_diluted": "USD/shares", "free_cash_flow": "USD", "gross_profit": "USD", "net_income": "USD", "operating_cash_flow": "USD", "operating_income": "USD", "revenue": "USD", "stockholders_equity": "USD", "total_assets": "USD", "total_liabilities": "USD" }, "fundamentals": { "capex": 603000.0, "cash": 6605000.0, "cost_of_revenue": 13027000.0, "eps_diluted": -1.91, "free_cash_flow": -37472000.0, "gross_profit": 32493000.0, "net_income": -47082000.0, "operating_cash_flow": -36869000.0, "operating_income": -40794000.0, "revenue": 45520000.0, "stockholders_equity": 34777000.0, "total_assets": 114106000.0, "total_liabilities": 79329000.0 }, "period_end": "2022-12-31", "ratio_units": { "gross_margin": "ratio", "leverage": "ratio", "net_margin": "ratio", "operating_margin": "ratio", "revenue_growth_yoy": "ratio", "roa_avg2y": "ratio", "roa_period_end": "ratio", "roe_avg2y": "ratio", "roe_period_end": "ratio" }, "ratios": { "gross_margin": 0.7138181019332162, "leverage": 2.2810765735974927, "net_margin": -1.0343145869947277, "operating_margin": -0.8961775043936732, "revenue_growth_yoy": 0.007458557422039262, "roa_avg2y": -0.38020252919230585, "roa_period_end": -0.4126163391933816, "roe_avg2y": -0.869634281492427, "roe_period_end": -1.353825804410961 } }, { "accn": "0001528287-24-000005", "filed": "2024-03-05", "fiscal_year": 2021, "form": "10-K", "fundamental_units": { "capex": "USD", "cash": "USD", "cost_of_revenue": "USD", "eps_diluted": "USD/shares", "free_cash_flow": "USD", "gross_profit": "USD", "net_income": "USD", "operating_cash_flow": "USD", "operating_income": "USD", "revenue": "USD", "stockholders_equity": "USD", "total_assets": "USD", "total_liabilities": "USD" }, "fundamentals": { "capex": 384000.0, "cash": 19187000.0, "cost_of_revenue": 11748000.0, "eps_diluted": -2.17, "free_cash_flow": -24961000.0, "gross_profit": 33435000.0, "net_income": -36080000.0, "operating_cash_flow": -24577000.0, "operating_income": -23737000.0, "revenue": 45183000.0, "stockholders_equity": 73503000.0, "total_assets": 133562000.0, "total_liabilities": 60059000.0 }, "period_end": "2021-12-31", "ratio_units": { "gross_margin": "ratio", "leverage": "ratio", "net_margin": "ratio", "operating_margin": "ratio", "revenue_growth_yoy": "ratio", "roa_avg2y": "ratio", "roa_period_end": "ratio", "roe_avg2y": "ratio", "roe_period_end": "ratio" }, "ratios": { "gross_margin": 0.7399907044684948, "leverage": 0.8170959008475844, "net_margin": -0.7985304207334617, "operating_margin": -0.5253524555695727, "revenue_growth_yoy": 0.09832758033934562, "roa_avg2y": -0.380767444805606, "roa_period_end": -0.2701367155328611, "roe_avg2y": 0.9708189266638863, "roe_period_end": -0.49086431846319195 } }, { "accn": "0001528287-23-000007", "filed": "2023-03-02", "fiscal_year": 2020, "form": "10-K", "fundamental_units": { "capex": "USD", "cash": "USD", "cost_of_revenue": "USD", "eps_diluted": "USD/shares", "free_cash_flow": "USD", "gross_profit": "USD", "net_income": "USD", "operating_cash_flow": "USD", "operating_income": "USD", "revenue": "USD", "stockholders_equity": "USD", "total_assets": "USD", "total_liabilities": "USD" }, "fundamentals": { "capex": 62000.0, "cash": 26390000.0, "cost_of_revenue": 10866000.0, "eps_diluted": -117.85, "free_cash_flow": -21671000.0, "gross_profit": 30272000.0, "net_income": -24278000.0, "operating_cash_flow": -21609000.0, "operating_income": -13051000.0, "revenue": 41138000.0, "stockholders_equity": -147832000.0, "total_assets": 55950000.0, "total_liabilities": 62360000.0 }, "period_end": "2020-12-31", "ratio_units": { "gross_margin": "ratio", "net_margin": "ratio", "operating_margin": "ratio", "roa_period_end": "ratio", "roe_avg2y": "ratio" }, "ratios": { "gross_margin": 0.7358646506879284, "net_margin": -0.5901599494384754, "operating_margin": -0.3172492585930283, "roa_period_end": -0.433923145665773, "roe_avg2y": 0.17517732031661506 } }, { "accn": "0001528287-22-000006", "filed": "2022-03-10", "fiscal_year": 2019, "form": "10-K", "fundamental_units": { "stockholders_equity": "USD" }, "fundamentals": { "stockholders_equity": -129350000.0 }, "period_end": "2019-12-31", "ratios": {} } ], "latest_filing": { "accn": "0001528287-26-000011", "filed": "2026-03-03", "form": "10-K" }, "note": "Static grepcent export of verified SEC companyfacts-derived values. Monetary values are raw reported units from grepcent's resolved facts; no scaling and no FX conversion. Capex, dividends, and buybacks are reported as positive outflow magnitudes. ROE/ROA include both period-end basis (site-consistent) and average-of-two-years basis where the prior-year denominator exists.", "schema_version": "1", "sic": "3841", "sic_description": "Surgical & Medical Instruments & Apparatus", "source_urls": { "sec_companyfacts": "https://data.sec.gov/api/xbrl/companyfacts/CIK0001528287.json", "sec_submissions": "https://data.sec.gov/submissions/CIK0001528287.json" }, "ticker": "NPCE" }